Teens diagnosed with attention deficit hyperactivity disorder (ADHD) often don’t take their medication regularly, and new Kaiser Permanente research finds the problem gets worse when they hit adulthood. The study also related non-adherence to ADHD medication with some negative health and social outcomes.
Kaiser Permanente research scientist uses her expertise in epidemiology and nutrition to improve outcomes for cancer patients and enhance their survivorship.
A long-term study that has produced important insights into menopause and women’s health at midlife is starting its 27th year with new federal funding from the National Institute on Aging (NIA) at 7 sites including the Kaiser Permanente Division of Research in Oakland.
Lisa A. Croen, PhD, director of the Kaiser Permanente Autism Research Program, was named a fellow of the International Society for Autism Research (INSAR) during the society’s annual meeting May 7.
Andy Avins, MD, MPH, has been studying what works, and what doesn't, in medical care ever since a chance encounter in the hospital library with a journal that introduced him to the concept of evidence-based medicine.
Even if emergency personnel were able to use the best stroke assessment tool available, most patients taken directly by ambulance to a comprehensive stroke center could have been treated at a primary stroke center instead, a new Kaiser Permanente study suggests.
The Autism Research Program at the Kaiser Permanente Division of Research is pursuing a new project to identify gaps in knowledge about gender, sexuality, and reproductive health among autistic people. Our KP Research Radio podcast explores the issue.
A combination of 3 healthy lifestyle factors is associated with a 70% lower risk of preterm birth, according to an analysis of data from a Kaiser Permanente study involving nearly 2,500 pregnant women in Northern California.
Kaiser Permanente study shows computerized interpretation of doctors’ echocardiogram reports can identify patients with aortic stenosis.
Kaiser Permanente study by adjunct investigator and oncologist/hematologist Minggui Pan, MD, PhD, quantifies impact of a virtual tumor board for rare type of cancer.